Back to Search Start Over

Genomic and metabolic analyses reveal antagonistic lanthipeptides in archaea

Authors :
Haoyu Liang
Zhi-Man Song
Zheng Zhong
Dengwei Zhang
Wei Yang
Le Zhou
Ethan A. Older
Jie Li
Huan Wang
Zhirui Zeng
Yong-Xin Li
Source :
Microbiome, Vol 11, Iss 1, Pp 1-12 (2023)
Publication Year :
2023
Publisher :
BMC, 2023.

Abstract

Abstract Background Microbes produce diverse secondary metabolites (SMs) such as signaling molecules and antimicrobials that mediate microbe-microbe interaction. Archaea, the third domain of life, are a large and diverse group of microbes that not only exist in extreme environments but are abundantly distributed throughout nature. However, our understanding of archaeal SMs lags far behind our knowledge of those in bacteria and eukarya. Results Guided by genomic and metabolic analysis of archaeal SMs, we discovered two new lanthipeptides with distinct ring topologies from a halophilic archaeon of class Haloarchaea. Of these two lanthipeptides, archalan α exhibited anti-archaeal activities against halophilic archaea, potentially mediating the archaeal antagonistic interactions in the halophilic niche. To our best knowledge, archalan α represents the first lantibiotic and the first anti-archaeal SM from the archaea domain. Conclusions Our study investigates the biosynthetic potential of lanthipeptides in archaea, linking lanthipeptides to antagonistic interaction via genomic and metabolic analyses and bioassay. The discovery of these archaeal lanthipeptides is expected to stimulate the experimental study of poorly characterized archaeal chemical biology and highlight the potential of archaea as a new source of bioactive SMs. Video Abstract

Subjects

Subjects :
Microbial ecology
QR100-130

Details

Language :
English
ISSN :
20492618
Volume :
11
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Microbiome
Publication Type :
Academic Journal
Accession number :
edsdoj.3d33d80f7f144a14a1b11858e45f2587
Document Type :
article
Full Text :
https://doi.org/10.1186/s40168-023-01521-1